These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 9366575)

  • 21. Porcine aortic smooth muscle cells secrete a serine protease for insulin-like growth factor binding protein-2.
    Gockerman A; Clemmons DR
    Circ Res; 1995 Apr; 76(4):514-21. PubMed ID: 7534656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis.
    Fowlkes JL; Serra DM; Rosenberg CK; Thrailkill KM
    J Biol Chem; 1995 Nov; 270(46):27481-8. PubMed ID: 7499205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteolytic cleavage of insulin-like growth factor binding protein 4 (IGFBP-4). Localization of cleavage site to non-homologous region of native IGFBP-4.
    Chernausek SD; Smith CE; Duffin KL; Busby WH; Wright G; Clemmons DR
    J Biol Chem; 1995 May; 270(19):11377-82. PubMed ID: 7538115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucocorticoid regulation of an insulin-like growth factor-binding protein-4 protease produced by a rat neuronal cell line.
    Cheung PT; Wu J; Banach W; Chernausek SD
    Endocrinology; 1994 Oct; 135(4):1328-35. PubMed ID: 7523095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that the interaction between insulin-like growth factor (IGF)-II and IGF binding protein (IGFBP)-4 is essential for the action of the IGF-II-dependent IGFBP-4 protease.
    Qin X; Byun D; Lau KH; Baylink DJ; Mohan S
    Arch Biochem Biophys; 2000 Jul; 379(2):209-16. PubMed ID: 10898936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic administration of insulin-like growth factor (IGF)-binding protein-4 (IGFBP-4) increases bone formation parameters in mice by increasing IGF bioavailability via an IGFBP-4 protease-dependent mechanism.
    Miyakoshi N; Qin X; Kasukawa Y; Richman C; Srivastava AK; Baylink DJ; Mohan S
    Endocrinology; 2001 Jun; 142(6):2641-8. PubMed ID: 11356715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts.
    Fowlkes J; Freemark M
    Endocrinology; 1992 Nov; 131(5):2071-6. PubMed ID: 1385096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of IGFBP-1 and IGFBP-2 and their fragments on migration and IGF-induced proliferation of human dermal fibroblasts.
    Brandt K; Grünler J; Brismar K; Wang J
    Growth Horm IGF Res; 2015 Feb; 25(1):34-40. PubMed ID: 25468444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin receptor mediates inhibitory effect of insulin, but not of insulin-like growth factor (IGF)-I, on IGF binding protein 1 (IGFBP-1) production in human granulosa cells.
    Poretsky L; Chandrasekher YA; Bai C; Liu HC; Rosenwaks Z; Giudice L
    J Clin Endocrinol Metab; 1996 Feb; 81(2):493-6. PubMed ID: 8636256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of insulin-like growth factor-binding protein-5 by insulin-like growth factor I and interleukin-1alpha in ovine articular chondrocytes.
    Sunic D; McNeil JD; Rayner TE; Andress DL; Belford DA
    Endocrinology; 1998 May; 139(5):2356-62. PubMed ID: 9564845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation.
    Fowlkes JL; Thrailkill KM; George-Nascimento C; Rosenberg CK; Serra DM
    Endocrinology; 1997 Jun; 138(6):2280-5. PubMed ID: 9165012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic alphaVbeta3 antagonists inhibit insulin-like growth factor-I-stimulated smooth muscle cell migration and replication.
    Clemmons DR; Horvitz G; Engleman W; Nichols T; Moralez A; Nickols GA
    Endocrinology; 1999 Oct; 140(10):4616-21. PubMed ID: 10499518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II.
    Gockerman A; Prevette T; Jones JI; Clemmons DR
    Endocrinology; 1995 Oct; 136(10):4168-73. PubMed ID: 7545099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity.
    Ricort JM; Binoux M
    Endocrinology; 2001 Jan; 142(1):108-13. PubMed ID: 11145572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment.
    Hakeda Y; Kawaguchi H; Hurley M; Pilbeam CC; Abreu C; Linkhart TA; Mohan S; Kumegawa M; Raisz LG
    J Cell Physiol; 1996 Feb; 166(2):370-9. PubMed ID: 8591997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration.
    Abrass CK; Berfield AK; Andress DL
    Am J Physiol; 1997 Dec; 273(6):F899-906. PubMed ID: 9435678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and insulin-like growth factor-dependent proteolysis of insulin-like growth factor-binding protein-4 are regulated by cell confluence in vascular smooth muscle cells.
    Kamyar A; Pirola CJ; Wang HM; Sharifi B; Mohan S; Forrester JS; Fagin JA
    Circ Res; 1994 Apr; 74(4):576-85. PubMed ID: 7511071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production of recombinant porcine IGF-binding protein-5 and its effect on proliferation of porcine embryonic myoblast cultures in the presence and absence of IGF-I and Long-R3-IGF-I.
    Pampusch MS; Xi G; Kamanga-Sollo E; Loseth KJ; Hathaway MR; Dayton WR; White ME
    J Endocrinol; 2005 Apr; 185(1):197-206. PubMed ID: 15817840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
    Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
    Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways in stimulation of vascular smooth muscle cell migration and deoxyriboncleic acid synthesis by insulin-like growth factor-I.
    Imai Y; Clemmons DR
    Endocrinology; 1999 Sep; 140(9):4228-35. PubMed ID: 10465296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.